Medications

Developing the first drug for a deadly bone disease

The U.S. Food and Drug Administration (FDA) recently approved palovarotene (Sohonos) as the first treatment for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes abnormal bone formation ...

Diseases, Conditions, Syndromes

Breathing memory depends heavily on time of day for hypoxia: Study

Neurochemical mechanisms that enable breathing memory—a form of neuroplasticity (the ability of the nervous system to change its activity in response to injuries) known as phrenic long-term facilitation—are very dependent ...

Psychology & Psychiatry

Depression, anxiety may be among early signs of multiple sclerosis

New research from the University of British Columbia is painting a clearer picture of the early signs of multiple sclerosis (MS), showing that people are nearly twice as likely to experience mental illness in the years leading ...

Diseases, Conditions, Syndromes

Rehabilitation interventions aid post-COVID-19 condition: Study

Standardized rehabilitation interventions are associated with improvements in functional exercise capacity in patients with post-COVID-19 condition (PCC), according to a review published online Sept. 19 in JAMA Network Open.

page 1 from 40